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Value relevance of R&D reporting: a signaling interpretation
ABSTRACT
Accounting for research and development (R&D) costs is an open issue. SFAS N°2 mandates
that all R&D costs are immediately expensed. International standards prescribe a
capitalization of R&D costs if they meet certain criteria (IAS 38). Recent research papers
(Healy et al., 2002; Lev and Sougiannis, 1996, 1999; Aboody and Lev, 1998, Zhao, 2002)
show that capitalization of R&D costs and software development costs is value relevant.
However critics can be leveled at previous research because prior empirical tests are based on
simulated or partial data.
Our purpose is to test empirically R&D accounting issues on a sample of 95 French firms on a
three years period (1998-2000). French context provides an experimental field for studying
the value relevance of R&D capitalization, because both accounting treatments of R&D costs
(expensing and capitalization) are allowed. We find that capitalized R&D is positively
associated with stock returns and stock prices, whereas expensed R&D is negatively related to
stock prices and stock returns. R&D accounting reduces the information asymmetry on the
successfulness of R&D projects: it acts as a signal to investors.
This paper extends previous literature by using real data on capitalized R&D, instead of
estimated data. Moreover, we show not only that capitalized R&D is value relevant but also
that expensing of R&D projects conveys a negative signal.
Key words: value relevance, R&D, France, financial reporting, capital markets, accounting
choice.3
0.  INTRODUCTION
This paper deals with the value relevance of research and development (R&D) costs’ financial
reporting. Accounting for R&D efforts is an open issue. US standard setters mandate that all
R&D costs are immediately expensed (SFAS N°2), whereas International standards prescribe
a capitalization of R&D costs if they meet certain criteria (IAS 38).
On one hand, proponents of the cost method argue that expensing is preferable to
capitalization because it eliminates the opportunity for managers to capitalize costs of projects
that have a low probability of success or to delay writing down impaired R&D assets. On the
other hand proponents of the capitalization method argue that R&D outlays generate some of
the most prized economic assets in the economy. As Rimerman (1990) notes “intangible,
unmeasured assets have great importance in an economy increasingly dependant on expertise,
data and technology, an economy in which an expanding service sector does not rely on fixed
assets as the primary generator of revenue”. As a consequence accountants refusal to
capitalize these expenditures as assets seriously affects the relevance of financial reporting.
Lev and Sougiannis (1999) argue that the significant decline in the relevance and the
usefulness of financial statements is due to the non recognition of intangible assets in the
balance sheet. To summarize, the cost method is perfectly objective and verifiable. The
capitalization of R&D costs may be used to convey information but is also less reliable. There
is a trade off between reliability and objectivity (Healy et al., 2002).
This trade off is of importance both to market participants and to standard setters. For
investors, the financial reporting of research and development outlays has a great impact on
the reported net income (if the R&D effort is not constant over time). Moreover, a uniform
way to report for R&D expenditures (e.g. cost method) disallows outsiders to properly4
evaluate the growth opportunity set in a context of information asymmetry. For standard
setters, the accounting of R&D outlays is important as it relates to their conceptual
framework. According to both the IASB and the FASB, financial reports should provide
useful information to investors. As a consequence, most of the literature (with some
exception, e.g. Boone and Raman, 2001) has concentrated on the value relevance of R&D
accounting regimes (expensing or capitalizing). An implicit assumption of the value relevance
approach is that an accounting rule is preferred if it improves the statistical association of
stock prices and/or returns with earnings, book values or other accounting variables. In the
case of R&D accounting, under the value relevance criterion, full cost accounting should be
adopted only if the value relevance of earnings and book value is higher than under a
recognition of R&D outlays as assets.
The empirical challenge for testing the value relevance of R&D regimes rests on the data
requirements. Such tests require a set of data with capitalizers and expensers, but most
standard setters require the cost method. Researchers developed three answers to this
challenge:
(1) The use of artificial data: since capitalization of R&D costs is not allowed in the US,
some authors chose to model the amounts of capitalized R&D. For instance, Lev and
Sougiannis (1996), Horwitz and Zhao (1997) and Chambers et al. (1998) developed a
model to price R&D assets if successful R&D outlays were capitalized instead of
being expensed. Healy et al. (2002) go even farther: they use Monte Carlo simulations
to generate financial statements of pharmaceutical firms. They were then able to test
the association between economic values (ROE, net present value of the firms,…) and
the R&D accounting treatment (full cost or successful efforts). Overall, those studies
document the value relevance of capitalizing R&D costs.5
(2) The use of real data: Other authors prefer to use real data  to create samples of
capitalizers and expensers. For instance Aboody and Lev (1998) studied software
development costs’ capitalization, which is the only exception in the United States to
the full expensing rule of R&D. The disadvantage of this approach is a scope’s
reduction compared to the previous studies.
(3) A comparative approach: Some authors choose to implement a comparative approach.
Since some accounting setters require full expensing of R&D expenses and other
authorize capitalization, it is possible to carry out value relevance studies on a sample
of international firms. For instance, Zhao (2002) notes that the USA or Germany
require a full expense of R&D costs, whereas France or the UK allow a capitalization
of such costs. Zhao (2002) compares the ability of accounting figures to explain share
prices in those countries.
Overall, previous studies conclude to a higher value relevance of capitalized R&D costs if
they meet certain criteria of successfulness instead of just expensing them. However, this
conclusion is based on studies that can be criticized. The relevance of studies with artificial
data is based on the ability of the researcher to compute an economically sound asset of R&D.
This ability can be questioned. For instance, Lev and Sougiannis (1996) use polynomial
Almon lag method that is highly dependant on the number of observations. The range of the
papers on software development costs capitalization are too narrow to be easily generalized.
Finally, comparative studies fail to control the many biases that can affects the empirical
findings (market microstructure, institutional factors, the functions of accounting across
countries,…)6
Our goal is to take advantage of a specific feature of the French institutional context. French
standard setters allow conditional capitalization of R&D costs or expensing of such R&D
costs. French firms have the option to choose the expensing or the capitalization of R&D
outlays (under conditions). This framework provides a laboratory experiment for an
accounting treatment of intangibles that differs from the nearly universal full expensing of
intangible assets. Under French GAAP, managers can signal to market participants the
expected return of their R&D outlays by capitalizing such costs
1. Since capitalization is an
option, managers can also align their practices on international standards and expense their
R&D outlays. This design offers a unique opportunity to assess the value relevance of R&D
accounting. More precisely, the issues raised by the value relevance of R&D accounting are
twofold. First, do market participants value R&D assets? This question is open due to the
trade off between relevance and reliability. A positive and significant association provides a
strong support to the IASB position. Second, if the recognition in the balance sheet of R&D
outlays is relevant, then expensing R&D outlays should provide a negative signal to the
market because unsuccessful investments can be expected.
Our research design is based on two value relevance studies (explanation of the cross
sectional returns and explanation of the year-end share price). Our sample is composed of 95
French listed firms which disclosed information on R&D on the 1998-2000 period. In France,
the income statement usually classifies expenses by nature rather than by function
2. R&D
expenses, like advertising expenses, are therefore not shown in French Group financial
statements, in contrast to the situation under US GAAP. The sample size is 254 observations
                                                
1 Only the cost of successful projects can be capitalized. To capitalized, R&D outlays must meet three criteria: to
be specific to an identifiable project, to be related to applied research (fundamental research is not eligible), to
have significant chances of commercial success. Given the last condition, only successful projects can be
recognized as assets.
2 Ding, Stolowy and Tenenhaus (2002) show that only 32 French companies, in the top 100, used the
presentation by function in 1998.7
due to data limitations. Our empirical findings suggest that capitalization of R&D costs is
value relevant. The recognition in the balance sheet of such assets is perceived as a positive
signal by the market. On the opposite, an expensing of R&D costs produces lower share
prices and lower returns (ceteris paribus).
The reminder of the paper is organized as follows. Section 1 describes our theoretical
background, section 2 presents our methodology, section 3 our empirical findings and section
4 concludes.
1.  THEORETICAL BACKGROUND
1.1.  Accounting treatment of Research & Development costs
Research and development reporting in French consolidated statement could  follow different
GAAP (but R&D reporting must follow French accounting rules in the individual accounts).
With the creation of CRC (Comité de la réglementation comptable, Règlement 99-02), quoted
companies could use either French rules or IAS GAAP or, until the 31
st December 2002,
international GAAP as US GAAP. As shown in table 1, the accounting treatments of R&D
costs are different across standards.
Insert Table 1
French rules state that R&D expenditures are expensed as incurred unless the project satisfies
certain conditions. PCG 99 ( Plan comptable général, 1999) express that: “Exceptionally,
applied research and development costs could be capitalized if the projects concerned are
clearly identifiable, their respective costs are distinctly evaluated, and each project has a
serious chance of technical success and commercial profitability” (Art. 361-2).
Capitalized R&D expenditures must be amortized over a period not exceeding 5 years. There
are no clearly established rules concerning the starting date for amortization. In exceptional
circumstances, and relating only to particular projects, R&D capitalized expenditures may be8
amortized over a longer period not exceeding the useful life of the assets. If R&D costs are
expensed as incurred, they shall be disclosed in the management report
3.
The capitalization of R&D costs under French rules remains an option for the company if the
project satisfy the above criteria. Thus the capitalization of R&D costs is a strategic decision
for the group. The literature suggests that when firms make reporting decisions, there is a
trade-off between the cost of revealing proprietary information and the resulting benefit
(Verrechia, 1983). This trade-off is likely to be very sensitive in the case of R&D reporting
because of its highly confidential nature.
On the other hand, no choice of R&D accounting treatment exists under US GAAP.
SFAS N°2 established standards of financial accounting and reporting for research and
development (R&D) costs. This statement requires that R&D costs to be expensed when
incurred. It also requires the company to disclose in its financial statements the amount of
R&D expensed (i.e. there is no optional treatment of R&D costs, but their amount is
available). However, separate rules apply to development costs for computer software that is
to be sold: capitalization (and amortization) applies once technological feasibility is
established. Capitalization ceases when the product is available for general release to
customers. Similar rules apply to certain elements of development costs for computer
software for internal use (SFAS N°86).
In conclusion, US GAAP do not allow capitalization of R&D costs, but require a distinct
disclosure of these costs.
                                                
3 In France, the income statement presentation usually presents a classification of expenses by nature rather than
by function. R&D expenses, like advertising expenses, are not therefore shown in French Group financial
statements, in contrast to the situation under US GAAP. All intangible expenditure is distributed between the
various operating expenses. For example, software development costs will be divided between personnel costs
for the employees who worked on the project, purchases of raw materials for any components, and other relevant
items in the same way.9
At last, French listed companies could follow the international standards. The objective of IAS
38 is to prescribe the accounting treatment for intangible assets that are not explicitly covered
in another IAS
4. IAS 38 mandates:
-  a full expensing of all research costs (IAS 38.42).
-  a capitalization of development outlays only if technical and commercial feasibility of
the asset for sale or use has been established. This means that the firm must intend and
be able to complete the intangible asset and either use it or sell it and be able to
demonstrate how the asset will generate future economic benefits (IAS 38.45)
An intangible asset (i.e. capitalized R&D) should be amortized over the best estimate of its
useful life (IAS 38.79). Nevertheless,  IAS 38 does not permit an enterprise to assign an
infinite useful life to an intangible asset. It includes a presumption that the useful life of an
intangible asset will not exceed 20 years. Impairment (IAS 36) applies to intangible assets.
There is a compulsory annual test if the amortization period exceeds 20 years or intangible is
not ready for use. Finally, additional disclosures are required about the amount of research
and development expenditure recognized as an expense in the current period (IAS 38.115).
1.2.  Value relevance of R&D outlays
French context provides an experimental field for studying the value relevance of R&D
capitalization, because both accounting treatment of R&D costs (expensing and
capitalization) are allowed.
Zhao (2002) studies the relative value relevance of R&D capitalization in France, the UK,
Germany and the USA. He shows that the reporting of total R&D costs increases the
                                                
4 IAS 9 (1993), « Research and development costs » was replaced by IAS 38 in July 1999.10
association of equity price with accounting earnings and book-value with complete R&D
accounting standards (Germany and the USA). The allocation of R&D costs between
capitalization and expense provides incremental information content over the disclosure of the
total R&D costs. However, this study presents caveats due to the international comparison.
Recent comparative studies indicate that earnings quality is subject to several country specific
factors other than legal systems (e.g. Pope and Walker, 1999; Ali and Hwang, 2000). Zhao
(2002) follows Francis and Schipper (1999) in examining only the information content of
R&D costs level. Lev and Zarowin (1999) find that change in R&D intensity bears significant
additional information and that it is necessary to control for industry effect in R&D
accounting research because industrial R&D is industry specific by nature (Lev and
Sougiannis, 1996).
The relation between the stock returns and investments in R&D has been extensively studied
in prior literature. For instance, Hirschey (1982) shows that, on average, advertising expenses
and R&D outlays have a positive and significant effect on the share price. Connolly and
Hirschey (1984) document the same relation between R&D expenses and share price on a
sample of 390 firms representing more than 90% of the R&D expense of the US industrial
firms. More recently, Lev and Sougiannis (1996) documented a significant and inter temporal
association between a capital of R&D and future stock returns. If R&D costs are relevant,
some authors suggest the existence of a systematic mispricing of the intensive R&D firms, or
of a compensation with a factor of risk. For instance, Chan et al. (2001) give support to this
proposition. They show that R&D intensive firms have low past returns and show signs of
mispricing.
Overall, these articles show:
-  a positive link between R&D expenses and various market values.11
-  that market participants’ perception of R&D effectiveness is blurred by information
asymmetry. As consequence, R&D outlays are mispriced by the market.
These conclusions raise the question of the value relevance of R&D outlays reporting.
Standard setters may require that all R&D be expensed immediately or could  authorize a
capitalization of R&D outlays under conditions. Capitalization (or expensing) of R&D efforts
is value relevant if a significant association is found with market values (share price or cross
sectional returns for instance).
Our research question is the following: “Is it possible to convey information on R&D by
reporting R&D as expenses or as assets”? This question is not trivial due to the trade off
between relevance and reliability in the case of R&D capitalization (Healy et al., 2002). As
noted by Lev and Sougiannis (1996, 1999), R&D capitalization is probably relevant because
it allows to reduce the information asymmetry between the firm and market participants.
Nevertheless, capitalizing such costs also creates an opportunity for managers to engage into
earnings management. Recognizing R&D as assets may impair financial reports reliability.
Our goal in this paper is to take advantage of the French local context:
-  Since, French standard setters authorize the recognition of R&D efforts either as an
expense or as an asset, we have the opportunity to study the value relevance of each
accounting treatment.
-  Compared to prior studies, we have an access to real data about capitalized R&D. As a
consequence, we do not have to compute an estimated R&D asset as in Lev and
Sougiannis (1999) or in Lev et al. (2002).12
-  We also have the opportunity to control the differences in accounting rules enforcement or
in market microstructure that can impair the relevance of comparative studies (as in Zhao,
2002).
Consistent with prior studies, we can state the following hypothesis:
H1:  Recognition of R&D outlays as assets is value relevant. We expect a positive and
significant association between capitalized R&D and market values.
Since French managers have the option to recognize development costs as assets, recognition
as expense should signal non profitable or non achieved R&D projects. We can state H2:
H2: Recognition of R&D outlays as expense conveys a negative information to the market.
We expect a negative and significant association between expensed R&D and markets values.
2.  DATA AND METHODOLOGY
2.1.  Sample
To carry out our research, we need  to create a sample of expensers and capitalizers among
the French listed firms. The main difficulty was to identify capitalizers because most of the
databases use a US format of balance sheet, where R&D assets are not identified. For
instance, on the Thomson financial database, R&D assets are registered as intangible assets
(as with brands, patents, other intangibles). To identify expensers, we use the Thomson
financial database (who reports the amount of R&D expensed). To identify capitalizers, we
use the DIANE (DIsque pour l’Analyse Economique) database, specialized on French firms.
Capitalized R&D is reported on a specific line of the balance sheet. Since there are doubts on
the reliability of this data base, we cross checked the data gathered from DIANE with the
information disclosed in  annual reports.13
95 large French listed firms compose our sample on a three year period (1998-2000). The
total sample size is 254 observations (firm-year), which can appear to be quite small given
that 1,404 non financial firms are present on the Thomson Financial database (table 2): our
sample represent only 6.77% of the French listed firms.
Insert Table 2
To explain this result, it should be noted that under French regulations, firms do not have to
disclose their R&D outlays. As a consequence, our sample is biased towards firms with an
incentive to disclose additional information. By comparing our sample with the total
population of listed firms, we note that our sample is biased towards high technology, high
growth firm, small capitalization (see table 3).
Insert Table 3
Since our sample is mainly compounded of high tech firms, we present the descriptive
statistics for each sub sample (high tech versus traditional firms) in table 4. On the whole, this
table suggests that high tech firms have higher growth opportunities (Price-Earnings-Ratio is
32.5% versus 15.52% for traditional firms, Price-to-Book ratio is 5.3 versus 2.8), are less
leveraged (25% of total assets versus 29.57%, significant at 5%), more risky (b is 1.30 versus
0.62 for traditional firms) and have smaller market capitalization (5.7 billions of euros versus
8.9 billions) than traditional firms.
Surprisingly the average R&D outlays per share (R&D per share) of high tech firms is not
statistically different from the average spending of traditional firms (RDPS: R&D per share)
as shown in table 4. This result is probably due to the sample bias (made of firms who
voluntarily disclosed information). However, as table 4 shows, high tech firms clearly choose14
to capitalize their R&D outlays. This feature of our sample is consistent with prior studies
(Ding and Stolowy, 2003).
Insert Table 4
2.2.  Research design
We examine the value relevance of R&D accounting treatment (expensed versus capitalized)
using two approaches: associating stock returns with contemporaneous financial data and
associating stock prices with financial data.
We control our models by the following variables coming from previous literature.
-  Size, measured by the market value of equity at the end of fiscal year. Large firms tend
to spend a substantial part of research and development costs on basic research, on
maintenance and upgrades of their products. Theses costs, and particularly basic
research costs are expensed accordingly to PCG 99,  IAS 38 or  SFAS N°2.
Consequently, large firms are expected to expense a larger part of development costs
than smaller firms.
-  Growth, measured by the annual change of sales. We expect that firms having the
higher level of growth are the most engaged in R&D.
-  ROE (Profitability), measured by the ratio return on equity per share. Given analysts’
scepticism about research and development capitalization, it is widely believed that
profitable companies avoid capitalization in order not to taint the perceived quality of
their earnings in analysts’ eyes.15
-  Leverage, measured by long-term debt divided by total capital
5. Leverage is a proxy
for the restrictiveness of loan covenants as motivators of capitalization; firms closer to
loan restrictions may favour capitalization which increases equity and earnings.
-  Systematic risk, or b. Basic research more risky than product development. Basic
research is also expensed according to French, international or US GAAP, while
product development could be capitalized. Thus riskier firms, namely, those devoting
a larger share of developments efforts to basic research, can be expected to expense
more than less risky companies.
-  Book-to-market ratio, indicates investors’ growth expectations irrespective of when
the underlying information reaches the market. This ratio allows to control for
performance and risk (Fama and French, 1992). We expect firms with high (low)
book-to-market ratio have low (high) R&D intensity.
2.2.1.  Stock returns model
First we examine the link between stock returns, annual R&D capitalization and expensed
R&D data using a model derived from the Fama and French (1992) and Aboody and Lev
(1998) models.
The association between capitalized R&D variable and contemporaneous annual stock returns
indicates the extent to which the information conveyed by R&D capitalization is used by
investors. Such a test cannot indicates whether investors actually used capitalization data in
assessing security values. We estimate the following cross sectional regression:
                                                
5 Total capital represents the total investment in the company. It is the sum of common equity, preferred stock,
minority interest, long-term debt, non-equity reserves and deferred tax liability in untaxed reserves.16
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With,
-  Rit: annual stock return at the end of year t for firm i.
-  RDESit: annual amount of expensed R&D costs to sales, for firm i and year t.
-  RDCapTAit: annual amount of net capitalized R&D costs to total assets, for firm i and year
t.
-  Ln(Sizeit): logarithm of market value of the firm i at the end of fiscal year t.
-  Growthit: rate of growth for company i, measured as change in sales between t and  t-1.
-  ROEit: return on equity ratio (earnings / book value) for firm  i at the end of year t. It
measures the profitability of the firm
-  Betait: measure of risk, CAPM-based beta of company i.
-  Levit: leverage ratio for firm i in year t, measured as long term debts on total capital.
-  Ln(BTPit): logarythm of book value (minus capitalized R&D) per share to price at the end
of year t.
-  HTit: dummy variable for industry group coded one for high-technology firms and zero for
traditional firms.
-  YRit: time indicator variable that equals to one if an observation is from fiscal year Y, and
zero otherwise.
If the annual capitalized R&D represents value relevant information to investors then a 2 in
model (1) should be positive. Since RDES is likely to include R&D expenditures incurred
before technical and/or commercial feasibility has been achieved, we predict a1 to be negative
and smaller than a2.17
We assume that while firms generally undertake positive expected value projects, achieving
technological or commercial feasibility (indicated by capitalization) confirms to investors that
the project has a positive expected value. Whereas R&D expensed could be seen as non
profitable or non achieved R&D projects, which are not considered as vehicle for value
creation.
2.2.2.  Stock price Model
Model (1) deals with the value relevance of the annual capitalized and expensed R&D costs.
To study the value relevance, in the association sense, of the R&D asset reported on the
balance sheet and the expensed R&D costs, we ran the following regression:
(2)                                                                                                            
) ln(
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With,
-  Pi,t: stock price at the end of the fiscal year t for firm i.
-  RDEPSi,t: annual amount of expensed R&D costs per share.
-  RDCapPSi,t: annual amount of net capitalized R&D costs per share.
-  EPSi,t: reported annual earnings per share.
-  BVPSi,t: book value of equity per share.
-  Ln(Sizeit), Betait, HTit and YRit: as defined above.
Model (2) was motivated by recent empirical work on earnings models, in which the market
value of the company is regressed on alternative measures of earnings, book value, and other
relevant information (Aboody and Lev, 1998, p. 172; Zhao, 2002, p.158).18
3.  EMPIRICAL FINDINGS
3.1.  Univariate tests
First, we carry out a few univariate tests to check the value relevance of R&D accounting
methods. Table 5 shows that no significant relation can be found between R&D outlays per
share (RDPS = RDEPS + change in RDCapPS) and stock returns, whatever may be their
recognition in financial statements (in the income statement or in the balance sheet).
However, the positive relation between price and R&D per share is positive and not far from
being significant at 5%.
Insert Table 5
As table 5 shows the relation between price (P) and the R&D reporting is contrary to what is
expected since RDCapPS (resp. RDEPS) is negatively (resp. positively) related to price. The
univariate correlation between RDCapTA (net RD costs capitalized) and return is significant
and positive as expected, but the correlation between RDES (RD expensed divided by sales) is
not significant.
Overall univariate tests indicate that R&D reporting in the financial statements matters to
explain the cross sectional variation of returns and the share price. However, the sign of the
relation is not clear due to high correlation between the financial reporting of R&D and
growth opportunities that have an impact on share price or return. Table 6 and table 7 show
that correlations between R&D outlays and various measures of performance (probably
related to share price and returns) are significant. Thus, we have to carry out multivariate tests
to control for potential opposite effects.
Insert Tables 6 and 719
3.2.  Multivariate tests
3.2.1.  Value relevance analysis
Table 8 represents the estimates for the stock returns regression, model (1), for the full sample
(panel A), for the traditional firms (panel B) and for the high-technology firms (panel C).
Insert Table 8
In panel A (total sample) the coefficient of annual capitalization of R&D (RDCapTA) has the
expected sign (2.544) and is highly statistically significant (t = 3.766). In addition, as reported
in panel C, the coefficient of capitalized R&D is positive and significant for high-tech
companies and insignificant for traditional firms, as reported in panel B.
In contrast to the large and highly significant coefficient of the capitalized R&D variable, the
estimated coefficient of expensed R&D costs (RDES) is negative (- 0.651), only significant at
10% (for panels A and C) and insignificant for panel B.
Coefficients for the size control variable, ln(Size), are positive and significant for the three
panels, whereas growth control variable presents a positive association with stock returns only
for the full sample and high-tech firms.
Evidence from the stock return analysis indicates that investors distinguish between
capitalized and expensed R&D costs; while values of the former are positively associated
with stock returns, values of the latter are negatively associated. This result indicates that
capitalization of R&D is not a signal of earnings manipulation, but is a relevant information
for investors of the firm’s value creation capacity.20
After having studied the effect of R&D  capitalization on stock returns, we examine its
influence on stock prices. Table 9 represents estimates of the stock price regression, model
(2), for the full sample (panel A), then for the traditional companies (panel B) and the high-
technology companies (panel C).
Insert Table 9
Table 9 indicates that the coefficient of capitalized R&D per share (RDCapPS) is statistically
significant and highly positive for the three samples (full, traditional and high-tech). The
coefficients are high relative to book value (26.095 versus 0.886, 40.021 versus 0.462 and
18.497 versus 1.643). On the other hand, as for the stock returns regression, the coefficient of
expensed R&D per share (RDEPS) is negative and significant for panel A, and negative and
insignificant in panels B and C.
In addition, as reported for the full sample, coefficients of earnings per share (EPS) and book
value per share (BVPS) have the expected sign, as for the ln(Size).
To summarize, our results show for both regressions a positive association between
capitalized R&D costs and stock return  or stock price and a negative relation between
expensed R&D and return or price. The way of reporting R&D costs seems obviously not to
be neutral, it carries a signal to investors. These results give support to the capitalization of
R&D when the project fulfils certain conditions, as recommended by  IAS 38 and PCG
99.Currently, capitalized R&D bears a value relevant and positive information for investors in
assessing the value of companies. And if one of the most important objective of financial21
accounting is to provide a useful information to investors
6, then capitalization of R&D should
be recommended.
3.2.2.  Robustness Tests
Our empirical findings clearly show that the market attributes value to the financial reporting
of R&D outlays. However, a systematic association between high levels of R&D outlays and
capitalization of such expenditures could impair our results.
To test, for that possibility, we run a logistic regression (3) to explain the determinants of the
accounting method for R&D costs. Specifically, we test the following model:
(3)                                                                                                                                     99                      
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RDCap is a dummy variable coded 1 if the firm capitalizes its R&D costs, 0 otherwise. RDPS
is the amount of R&D outlays per share. We compute  RDPS as ( RDEPS +  change in
RDCapPS)
7. All other variables were previously defined. The assumptions for this model are
the following:
(1)  Managers can decide to use accounting for R&D to manage their contractual
relations. As a consequence, a significant relation is supposed between leverage, size
and the decision to capitalize R&D.
(2)  As noted earlier, capitalization may be preferred by high tech firms because of the
importance of their R&D costs. As a consequence, HT and Ln(BTP) are supposed to
influence the decision to capitalize R&D costs.
                                                
6 “The objective of financial statements  is to provide information about the financial position, performance and
changes in financial position of an enterprise that is useful to a wide range of users in making economic
decisions”, IAS Framework.
7 We tried other scaling variables (total assets, sales). Results (not reported) are qualitatively similar.22
(3)  To test the association between the R&D accounting and the level of R&D outlays,
the variable RDPS is added as an exploratory variable.
(4)  Beta and YR are control variables (defined above).
We carry out this model over our full sample. Table 10 presents the empirical results. Overall
the model is significant (Nagelkerke R² is 0.613). The level of R&D per share seems to be




As a consequence, our empirical findings of the previous section may only reflect the fact that
capitalizers spend more in R&D and have higher returns and higher share prices (all other
things being equal). To test for that possibility, we compute again the return regression (resp.
stock price regression) substituting  RDPS to  RDCapTA and  RDES  (resp.  RDCapPS and
RDEPS). Our goal is to check the existence of a systematic effect of R&D on returns and
share prices.
Tables 11 and 12 shows our results. Returns (table 11) are not explained by the overall R&D
outlays. Since table 8 reports significant association between RDCapPS and RDEPS, it means
that investors attach a different information content on R&D outlays according to their
accounting treatment.
Stock price is negatively associated with  RDPS (research and development per share, see
table 12). As a consequence, the positive coefficient found in table 9 on RDCapPS is all the
more significant and reliable that, on average, R&D outlays have a negative impact on share
price.
                                                
8 The robustness of this result was checked by using different procedures to run the logistic regression: ascending
or descending (tables not reported). RDPS was always significant.23
Insert Tables 11 and 12
Those results suggest that our empirical findings are not driven by a R&D level effect
9.
4.  CONCLUSION AND AVENUES FOR FUTURE RESEARCH
We examined the value relevance of R&D accounting treatment (expensing versus
capitalization) on a sample of French listed companies. Our results indicate on one hand that
R&D capitalization-related variables ( RDCapTA and  RDCapPS) are significantly and
positively associated with stock returns and prices. On the other hand, R&D expensed-related
variables (RDES and RDEPS) are negatively or not associated with stock prices and returns.
We conclude that R&D capitalization summarizes relevant information for investors and
reflects the profitability of R&D projects.
The negative sign of the association of the R&D costs incurred by expensers and market
values (price and returns) could reflect investors’ reaction to the absence of compulsory
disclosure of information about R&D in France in the financial reports. Especially, two biases
exist:
-  Best firms’ confidentiality. Firms with high quality R&D do not desire to disclose their
research level, nor their advertising and training expenditures because the disclosure
of such costs may provide relevant information to competitors.
-  Worst firms’ jamming effect. Poorly performing firms have an incentive to disclose
high level of R&D to signal favourable future prospects to the market. The
                                                
9 Our results are not driven by other sources of information correlated with the accounting choice concerning
R&D because Ding and Stolowy (2003) show no significant association between R&D reporting and the level of
voluntary disclosure.24
information on R&D is not easily verifiable and managers could disclose information
on R&D as to manipulate market participants’ beliefs.
In addition to these economic effects, Luft and Shields (2003), using an experimental
approach, note that market participants undervalue the future effect of R&D when R&D
outlays are expensed. They explain this empirical finding by psychological biases
(fixation,…).
Overall, our findings give support to a capitalization of R&D costs under conditions of
commercial success. The accounting treatment of R&D carries a signal to investors. This
result gives support to the capitalization of R&D when the project fulfil certain conditions, as
recommended by IAS 38 and PCG 99. And if providing useful information to investors is one
of the most important objective of financial accounting, then capitalization of R&D should be
recommended. However, our research suffers from limits and future avenues of research can
be suggested.
Our study belongs to the value relevance literature that has been extensively criticized since
2001 (Holthausen and Watts, 2001; Ronen, 2001). Even if some authors disagree with such
critics (e.g. Barth, Beaver and Landsman, 2001), it is clear that the information content of
financial reporting is not limited to the association of accounting numbers with market values.
A first possibility would be a study of the interaction between voluntary disclosure and value
relevance of R&D. Such study would allow us to test if the significance of R&D reporting is
due to the absence of alternative sources of information or to a signal conveyed by R&D
reporting. A possible further investigation of our sample, would be to test the impact of R&D
financial reporting on information asymmetry (measured by the bid-ask spread as in Leuz and25
Verrechia, 2000). If our interpretation in terms of signal is correct, than we should expect a
smaller bid-ask spread for capitalizers than for expensers.
Another possibility to further investigate our results would be to explore the factors that
influence the credibility of the signal provided by capitalizers. Since considerable discretion
exists to recognize R&D outlays as assets, managers can use opportunistically this accounting
choice. Some institutional and corporate governance factors probably influence the choice of
capitalizing R&D costs and the credibility of this signal.26
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Table 1  -   R&D Accounting treatments
R&D expensed as incurred R&D capitalized Standards
General rule Disclosed Separately Allowed Option Amortization & Impairment
French GAAP Art. 361-2, PCG 99 Yes No Yes, under conditions Yes Amortized over 5 years max
SFAS N°2 Yes Yes No US GAAP
SFAS N°86 (software
development costs)
Yes Yes Yes, if technological
feasibility
Yes Amortized over economic life
International
GAAP
IAS 38 & IAS 36 Yes Yes Yes, under conditions No Amortized over useful life
Impairment test if useful life > 20 years
Table 2  -   Sample constitution
From Thomson financial database Number of
observations
Firms listed on the French stock exchange 1477
Excluding banks, financial services, insurance (33)
Total 1404
Number of firms in our sample 95
                                        - % of listed firms 6,77%
Number of potential observations over the 1998-2000 period (95*3) 285
Number of valid observations 254
                                       - % of potential observations 89%29
Table 3  -   Descriptive statistics for the full sample
  Full sample All French listed firms Diff.
Mean S.E. Mean S.E.
HT 50% 0.5 4% 0.1981 yes
Beta 0.96 0.92 0.78542 0.9062 yes
Lev 27.37% 17.54 24.14% 57.55 no
Ln(BTP) 4.02 5.62 4.2018 19.98 yes
Ln(Size) 7328.56 18639.03 1632.22 8880.51 yes
Growth 20.19 32.85 31.58 103.21 no
  N=254   N=1,404    
HT is a dummy variable for industry group coded 1 for high-technology firms, 0 otherwise, Beta is the CAPM
specific risk, Lev is the ratio of long term debts to total capital, ln(BTP) is the log of the book-to-market ratio,
ln(Size) is the log of the year-end market value, Growth is the annual change of Sales.30
Table 4  -   Comparison of low tech and high tech sub samples
Beta Lev PER ln(PTB) ROE ln(size) RDPS RDEPS RDCapPS RDCap
Mean S.E. Mean S.E. Mean S.E. Mean S.E. Mean S.E. Mean S.E. Mean S.E. Mean S.E. Mean S.E. Mean S.E.
Low tech firms 0.62 0.53 29.57 15.19 15.52 73.67 1.02 0.92 12.81 14.43 9.10 9.99 194.2 394.85 192.14 393.34 0.07 0.25 0.2 0.4
High tech firms 1.3 1.1 25.14 19.45 32.5 262.6 1.67 2.00 9.2 23.54 8.65 9.59 111.18 179.35 107.86 177.49 0.22 0.41 0.41 0.49
N(low tech/high
tech) 126/128 126/128 126/128 126/128 126/128 126/128 97/99 98/102 126/120 126/128
P - level for T tests 5.90% 5.00% 0.01% <0.01%
Beta is the CAPM specific risk, Lev is the ratio of long term debts to total capital , PER is the price earnings ratio, ln(BTP) is the log of the book-to-market ratio, ROE is the
earnings on equity ratio, ln(Size) is the log of the year-end market value, RDPS is the R&D costs per share either expensed or capitalized and is computed as (RDEPSi+
change in RDCapPSi), RDEPSit is the annual RD costs expensed per share, RDCapPSit is the net capitalized RD costs per share, RDCap is a dummy variable coded 1 if the
firm capitalizes its R&D costs, 0 otherwise.31















Rit is the firm’s annual stock return , Pit is the firm’s stock price at the end of year t, RDPS is the R&D costs per
share either expensed or capitalized and is computed as (RDEPS+ change in RDCapPS), RDEPSit is the annual
RD costs expensed per share, RDCapPSit is the net capitalized RD costs per share, RDESit is the annual RD costs
expensed on sales, RDCapTAit is the net capitalized RD costs on Total Assets.32
Table 6  -   Correlation matrix, Stock returns regression
N = 254 observations
RDES RDCapTA ln(Size) Growth ROE Beta Lev ln(BTP) HT YR00 YR99
RDES Pearson's Correlation 1.000
Sig. .
RDCapTA Pearson's Correlation 0.239 1.000
Sig. 0.000.
ln(Size) Pearson's Correlation 0.072 -0.173 1.000
Sig. 0.253 0.006.
Growth Pearson's Correlation 0.022 0.030 0.046 1.000
Sig. 0.728 0.640 0.468.
ROE Pearson's Correlation -0.202 -0.072 0.187 0.352 1.000
Sig. 0.001 0.256 0.003 0.000.
Beta Pearson's Correlation 0.104 0.165 0.233 0.203 0.183 1.000
Sig. 0.099 0.008 0.000 0.001 0.003.
Lev Pearson's Correlation -0.042 -0.144 0.056 0.096 -0.138 0.059 1.000
Sig. 0.509 0.021 0.378 0.126 0.028 0.346.
ln(BTP) Pearson's Correlation -0.170 -0.237 -0.268 -0.125 -0.185 -0.332 -0.001 1.000
Sig. 0.007 0.000 0.000 0.046 0.003 0.000 0.988.
HT Pearson's Correlation 0.172 0.166 -0.225 0.208 -0.092 0.370 -0.126 -0.264 1.000
Sig. 0.006 0.008 0.000 0.001 0.142 0.000 0.044 0.000.
YR00 Pearson's Correlation 0.003 0.006 0.031 0.142 -0.046 0.013 0.045 -0.005 0.014 1.000
Sig. 0.962 0.928 0.628 0.023 0.469 0.833 0.474 0.942 0.824.
YR99 Pearson's Correlation 0.008 -0.011 0.017 0.026 0.058 0.016 0.002 0.007 0.006 -0.525 1.000
Sig. 0.896 0.856 0.789 0.683 0.353 0.795 0.976 0.911 0.929 0.000.
RDESit is the annual RD costs expensed on sales, RDCapTAit is the net capitalized RD costs on Total Assets, ln(Size) is the log of the year-end market value, Growth is the
annual change of Sales, ROE is the earnings on equity ratio, Beta is the CAPM specific risk, Lev is the ratio of long term debts to total capital, ln(BTP) is the log of the book-
to-market ratio,  HT is a dummy variable for industry group coded 1 for high-technology firms, 0 otherwise, and YR, is a time indicator variable that equals 1 if the
observation is from fiscal year Y, and 0 otherwise.33
Table 7  -   Correlation Matrix, Stock price regression
RDEPS RDCapPS EPS BVPS ln(Size) Beta HT YR00 YR99
REDPS Pearson's correlation 1
Sig. .
N 200
RDCapPS Pearson's correlation -0.234 1
Sig. 0.001.
N 192 246
EPS Pearson's correlation 0.129 -0.177 1
Sig. 0.075 0.014.
N 192 192 192
BVPS Pearson's correlation 0.506 -0.247 0.618 1
Sig. 0.000 0.001 0.000.
N 192 192 192 192
ln(Size) Pearson's correlation 0.148 -0.470 0.248 0.155 1
Sig. 0.036 0.000 0.001 0.032.
N 200 246 192 192 254
Beta Pearson's correlation -0.071 -0.148 -0.150 -0.272 0.233 1
Sig. 0.318 0.020 0.037 0.000 0.000.
N 200 246 192 192 254 254
HAT Pearson's correlation -0.138 0.211 -0.412 -0.421 -0.225 0.370 1
Sig. 0.051 0.001 0.000 0.000 0.000 0.000.
N 200 246 192 192 254 254 254
YR00 Pearson's correlation 0.060 0.057 0.062 0.078 0.031 0.013 0.014 1
Sig. 0.401 0.377 0.395 0.283 0.628 0.833 0.824.
N 200 246 192 192 254 254 254 254
YR99 Pearson's correlation 0.035 -0.025 -0.021 0.037 0.017 0.016 0.006 -0.525 1
Sig. 0.627 0.693 0.777 0.613 0.789 0.795 0.929 0.000.
N 200 246 192 192 254 254 254 254 254
RDEPSit is the annual RD costs expensed per share, RDCapPSit is the net capitalized RD costs per share, EPS is the reported earnings per share, BVPS is the book value of
equity per share, ln(Size) is the log of the year-end market value, Beta is the CAPM specific risk, HT is a dummy variable for industry group coded 1 for high-technology
firms, 0 otherwise, and YR, is a time indicator variable that equals 1 if the observation is from fiscal year Y, and 0 otherwise.34
Table 8  -   Stock returns regression
t i t i t i t i t i t i t i t i t i t i t i t i YR a HT a BTP a Lev a Beta a ROE a Growth a Size a RDCapTA a RDES a a R , , 10 , 9 , 8 , 7 , 6 , 5 , 4 , 3 , 2 , 1 0 , ) ln( ) ln( e + + + + + + + + + + + =
Panel A: Full sample
Constant RDES RDCapTA Ln(Size) Growth ROE Beta Lev Ln(BTP) HT YR00 YR99
Coef. -48.075 -.651 2.544 6.981 .549 .026 6.602 -.217 -5.622 4.493 2.423 22.545
T-test -3.376 -2.389 3.766 4.219 4.251 .115 1.375 -.696 -1.386 .484 .264 2.469
Sig. .001 .018 .000 .000 .000 .909 .170 .334 .167 .629 .792 .014
R² .292
Adjusted R² .260
F 9.157 Sig. .000
Panel B: Traditional industry
Constant RDES RDCapTA Ln(Size) Growth ROE Beta Lev Ln(BTP) YR00 YR99
Coef. -46.667 -2.160 -.710 6.317 .043 .234 -.059 .366 -3.192 -8.633 30.130
T-test -2.564 -1.423 -.175 2.818 .214 .791 -.006 1.259 -.717 -.890 3.166
Sig. .012 .157 .861 .006 .831 .430 .995 .211 .475 .375 .002
R² .273
Adjusted R² .211
F 4.404 Sig. .000
Panel C : High-technology industry
Constant RDES RDCapTA Ln(Size) Growth ROE Beta Lev Ln(BTP) YR00 YR99
Coef. -53.100 -.737 2.499 9.252 .783 -.128 5.518 -.714 -8.816 15.155 17.762
T-test -2.787 -2.205 3.009 3.285 4.232 -.370 .879 -2.097 -1.262 .963 1.154
Sig. .006 .029 .003 .001 .000 .712 .381 .038 .210 .337 .251
R² .369
Adjusted R² .314
F 6.722 Sig. .000
Regression results are based on 254 firm-years (Panel A), 127 firm-years (Panel B), 125 firm-years (Panel C).
Rit is the firm’s annual stock return, RDESit is the annual RD costs expensed on sales, RDCapTAit is the net capitalized RD costs on Total Assets, ln(Size) is the log of the
year-end market value, Growth is the annual change of Sales, ROE is the earnings on equity ratio, Beta is the CAPM specific risk, Lev is the ratio of long term debts to total
capital, ln(BTP) is the log of the book-to-market ratio, HT is a dummy variable for industry group coded 1 for high-technology firms, 0 otherwise, and YR, is a time indicator
variable that equals 1 if the  observation is from fiscal year Y, and 0 otherwise.35
Table 9  -   Stock price regression
t i t i t i t t i t i t i t i t i t i YR b HT b Beta b Size b BVPS b EPS b RDCapPS b RDEPS b b P , , 8 , 7 , 6 , 5 , 4 , 3 , 2 , 1 0 , ) ln( e + + + + + + + + + =
Panel A: Full sample                
  Constant RDEPS RDCapPS EPS BVPS Ln(Size) Beta YR00 YR99 HT
Coef. -34.821 -0.015 26.095 2.798 0.886 9.252 -2.086 -2.328 1.811 9.055
T-test -3.519 -1.875 3.870 3.080 5.039 9.544 -0.809 -0.323 0.248 1.778





F 24.376 Sig. 0.000            
Panel B: traditional industry              
  Constant RDEPS RDCapPS EPS BVPS Ln(Size) Beta YR00 YR99 HT
Coef. -40.473 -0.008 40.021 3.891 0.462 10.758 -12.627 4.628 12.232
T-test -2.531 -0.832 2.894 2.825 1.801 5.888 -1.642 0.400 1.060





F 9.702 Sig. 0.000            
Panel C: High technology industry
Constant RDEPS RDCapPS EPS BVPS Ln(Size) Beta YR00 YR99 HT
Coef. -25.203 -0.023 18.497 1.436 1.643 8.472 0.738 -6.448 -7.357
T-test -2.366 -1.324 2.644 1.243 6.806 7.42 0.315 -0.789 -0.883





F 22.423 Sig. 0.000            
Regression results are based on 192 firm-years (Panel A), 95 firm-years (Panel B), 95 firm-years (Panel C).
Pit is the firm’s stock price at the end of year t, RDEPSit is the annual RD costs expensed per share, RDCapPSit is the net capitalized RD costs per share, EPS is the reported
earnings per share, BVPS is the book value of equity per share, ln(Size) is the log of the year-end market value, Beta is the CAPM specific risk, HT is a dummy variable for
industry group coded 1 for high-technology firms, 0 otherwise, and YR, is a time indicator variable that equals 1 if the observation is from fiscal year Y, and 0 otherwise.36
Table 10  -  Accounting choice regression
t i t i YR YR Lev HT Beta BTP RDPS Size RDCap , 8 7 6 5 4 3 2 1 , 99 00 ) ln( ) ln( e b b b b b b b b a + + + + + + + + + =
Panel A: Full sample                
Constant Ln(Size) RDPS Ln(BTP) Beta HT Lev YR00 YR99
Wald 16.338 21.916 12.827 8.663 0.227 0.124 0.118 4.694 5.810
Sig. 0.000 0.000 0.000 0.003 0.634 0.725 0.731 0.030 0.016
Cox & Snell R² 0.449
Nagelkerke R² 0.613
                   
Regression results are based on 196 firm-years (Panel A).
RDCapit is a dummy variable coded 1 if the firm capitalizes its R&D costs, 0 otherwise, ln(Size) is the log of the year-end market value, RDPS is the total R&D outlays per
share, Ln(BTP) is the log of the Book-to-Price ratio, Beta is the CAPM specific risk,  HT is a dummy variable for industry group coded 1 for high-technology firms, 0
otherwise, Lev is the leverage ratio of the firm and YR, is a time indicator variable that equals 1 if the observation is from fiscal year Y, and 0 otherwise.
Table 11  -  Return regression with R&D outlays per share
t i t i t i t i t i t i t i t i t i t i t i YR a HT a BTP a Lev a Beta a ROE a Growth a Size a RDPS a a R , , 9 , 8 , 6 , 6 , 5 , 4 , " , 2 , 1 0 , ) ln( ) ln( e + + + + + + + + + + =
Panel A: Full sample                    
constant RDPS Ln(Size) Growth ROE b Lev Ln(BTP) HT YR00 YR99
Coef. -27.977 -0.026 5.963 0.477 0.012 9.693 -0.428 -6.031 1.773 -0.701 18.392
T-test -1.359 -1.617 2.880 3.044 0.043 1.638 -1.561 -1.273 0.147 -0.043 1.126
Sig. 0.176 0.108 0.004 0.003 0.966 0.103 0.120 0.205 0.883 0.966 0.262
R² 0.206
Adjusted R² 0.163
F 4.806 Sig. 0.000
                       
Regression results are based on 254 firm-years (Panel A).
Rit is the firm’s annual stock return, RDPS is the total R&D outlays per share, ln(Size) is the log of the year-end market value, Growth is the annual change of Sales, ROE is
the earnings on equity ratio, Beta is the CAPM specific risk, Lev is the ratio of long term debts to total capital, ln(BTP) is the log of the book-to-price ratio, HT is a dummy
variable for industry group coded 1 for high-technology firms, 0 otherwise, and YR, is a time indicator variable that equals 1 if the observation is from fiscal year Y, and 0
otherwise.37
Table 12  -  Stock price regression with R&D outlay
t i t i t i t t i t i t i t i t i YR b HT b Beta b Size b BVPS b EPS b RDPS b b P , , 7 , 6 , 5 , 4 , 3 , 2 , 1 0 , ) ln( e + + + + + + + + =
Panel A: Full sample                
Constant RDPS EPS BVPS Ln(Size) Beta HT YR00 YR99
Coef. -14.864 -0.018 2.987 0.816 7.700 -3.590 11.675 -6.140 -2.903
T-test -1.696 -2.154 3.172 4.493 8.407 -1.358 2.230 -0.828 -0.389




                   
Regression results are based on 192 firm-years (Panel A);
Pit is the firm’s stock price at the end of year t, RDPSit is the annual total R&D outlays per share, EPS is the reported earnings per share, BVPS is the book value of equity per
share, ln(Size) is the log of the year-end market value, Beta is the CAPM specific risk, HT is a dummy variable for industry group coded 1 for high-technology firms, 0
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